Titel

Merkliste
1 Ergebnisse

Safety and efficacy of the miR-124 upregulator ABX464 (obef..:

Daien, Claire ; Krogulec, Marek ; Gineste, Paul...
info:eu-repo/semantics/altIdentifier/doi/10.1136/annrheumdis-2022-222228. , 2022

Link: https://hal.science/hal-03684065

RT Journal
T1 <Title>Safety and efficacy of the miR-124 upregulator ABX464 (obefazimod, 50 and 100 mg per day) in patients with active rheumatoid arthritis and inadequate response to methotrexate and/or anti-TNFα therapy: a placebo-controlled phase II study</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftccsdartic:oai:HAL:hal-03684065v1&Exemplar=1&LAN=DE
				
A1 Daien, Claire
A1 Krogulec, Marek
A1 Gineste, Paul
A1 Steens, Jean-Marc
A1 Desroys Du Roure, Laurence
A1 Biguenet, Sophie
A1 Scherrer, Didier
A1 Santo, Julien
A1 Ehrlich, Hartmut
A1 Durez, Patrick
PB HAL CCSD; BMJ Publishing Group
YR 2022
K1 antirheumatic agents
K1 arthritis
K1 rheumatoid
K1 methotrexate
K1 [SDV.MHEP.RSOA]Life Sciences [q-bio]/Human health and pathology/Rhumatology and musculoskeletal system
K1 [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology
JF info:eu-repo/semantics/altIdentifier/doi/10.1136/annrheumdis-2022-222228
LK http://dx.doi.org/https://hal.science/hal-03684065
DO https://hal.science/hal-03684065
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)